Methods and apparatus for improved luminescence assays
Abstract
What is described are methods and apparatus for performing a binding assay for an analyte of interest present in a sample. The methods include the steps of: forming a composition containing the sample, an assay-performance-substance which contains a component linked to a label compound capable of chemiluminescing when triggered, and a plurality of particles capable of specifically binding with the analyte and/or the assay-performance-substance; incubating the composition to form a complex which includes a particle and the labeled component; collecting the complex in a collection zone; introducing into the collection zone a trigger capable of triggering the label such that the label luminesces; and measuring the emitted luminescence to measure the presence of the analyte of interest in the sample.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method for performing a binding assay for an analyte of interest present in a sample comprising the steps of:
(a) forming a composition containing
(i) said sample
(ii) an assay-performance-substance which contains a component linked to a label compound capable of chemiluminescing when triggered, and
(iii) a plurality of particles capable of specifically binding with the analyte and/or said assay-performance-substance;
(b) incubating said composition to form a complex which includes a particle and said labeled component; (c) collecting said complex in a collection zone; (d) introducing into said collection zone a trigger capable of triggering said label such that said label luminesces; and (e) measuring the emitted luminescence to measure the presence of the analyte of interest in the sample.
2 . A method as recited in claim 1 wherein said trigger is an oxidant capable of oxidizing said label.
3 . A method as recited in claim 1 wherein said particles are magnetically responsive and said complex is magnetically collected in said collection zone.
4 . A method as recited in claim 2 wherein said oxidant is hydrogen peroxide or superoxide.
5 . A method as recited in claim 1 wherein said assay-performance-substance further contains an enzyme for converting a precursor to an oxidant capable of oxidizing said label, and said trigger is the precursor.
6 . A method as recited in claim 5 wherein the enzyme is glucose oxidase, the precursor is glucose and the oxidant is hydrogen peroxide.
7 . A method as recited in claim 1 wherein said particles further contain an enzyme for converting a precursor to an oxidant capable of oxidizing said label, and said trigger is the precursor.
8 . A method as recited in claim 7 wherein the enzyme is glucose oxidase, the precursor is glucose and the oxidant is hydrogen peroxide.
9 . A method as recited in claim 1 conducted as a batch process, the composition being permitted to reside within said cell for a time sufficient to permit collection of said particles.
10 . A method as recited in claim 1 conducted as a flow process wherein said composition is flowed through said cell at a sufficiently low rate to permit collection of at least a portion of said particles.
11 . An assay method as recited in claim 7 wherein said particles have a density of from 0.1 to 5 g/mL.
12 . An assay method as recited in claim 11 wherein said particles have a density of from 0.5 to 2 g/mL.
13 . An assay method as recited in claim 7 wherein the size of said particles, measured as the mean diameter, ranges from 0.001 to 100 μm.
14 . An assay method as recited in claim 13 wherein the size of said particles ranges from 0.01 to 10 μm
15 . An assay method as recited in claim 7 wherein the concentration of particles in said composition is from 1 to 10,000 μg/mL.
16 . An assay method as recited in claim 15 wherein said concentration of particles is in the range of from 5 to 1000 μg/mL.
17 . An assay method as recited in claim 7 wherein said particles have a magnetic susceptibility of at least 0.001 cgs units.
18 . A method as recited in claim 17 wherein the magnetic susceptibility is at least 0.01 cgs units.
19 . An assay method as recited in claim 7 wherein the magnetic susceptibility, density, size and concentration of said particles in said composition is such that the settling rate of said particles is at least 0.5 mm/mim.
20 . An apparatus for performing a binding assay for an analyte of interest present in a sample based upon measurement of chemiluminescence comprising:
(a) a cell defining a sample containing volume having a vertical columnar zone and having inlet and outlet means, and further including means for generating a magnetic field positioned below a substantial volume of said cell and said columnar zone; and (b) means to measure the chemiluminescence generated at a collection zone.
21 . An apparatus as recited in claim 20 wherein said means for generating a magnetic field includes a plurality of magnets in north-south orientation and separated by nonmagnetic material.Join the waitlist — get patent alerts
Track US2003008339A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.